P970: SAFETY AND EFFICACY OF BCMA-CAR-T IMMUNE CELLS DERIVED FROM CORD BLOOD IN THE TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA

• Y. Wang,
• X. Hu,
• Q. Gao,
• H. Wang,
• Y. Gao,
• W. Zhang,
• X. Ru,
• L. Hou,
• W. Zhou,
• H. Zhang,
• Y. Zhang,
• F. Wang,
• X. Li,
• F. Guan

Affiliations

Y. Wang

1 Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’An

X. Hu

1 Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’An

Q. Gao

1 Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’An

H. Wang

1 Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’An

Y. Gao

1 Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’An

W. Zhang

1 Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’An

X. Ru

1 Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’An

L. Hou

1 Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’An

W. Zhou

1 Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’An

H. Zhang

1 Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’An

Y. Zhang

1 Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’An

F. Wang

2 School of Medicine, Shanghai Jiao Tong University, Shanghai

X. Li

3 School of Medicine, Northwest University, Xi’An, China

F. Guan

3 School of Medicine, Northwest University, Xi’An, China